MedPath

PeptiDream

🇯🇵Japan
Ownership
-
Employees
603
Market Cap
$2.3B
Website
Introduction

PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates. It discovers constrained peptides, small molecules, and peptide-drug conjugate therapeutics using its Peptide Discovery Platform System. The company aspires to be a leader in drug discovery and development to address unmet medical needs and improve the quality of life of patients worldwide.

© Copyright 2025. All Rights Reserved by MedPath